MassMutual Private Wealth & Trust’s Agios Pharmaceuticals AGIO Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-5,493	Closed	-$253K	–	853
2018 Q4	$253K	Sell	5,493 -60	-1%	-$3.7K	0.02%	299
2018 Q3	$428K	Buy	5,553 +471	+9%	+$37.9K	0.03%	281
2018 Q2	$428K	Buy	5,082 +287	+6%	+$25K	0.03%	265
2018 Q1	$392K	Buy	+4,795	New	+$371K	0.03%	263

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MassMutual Private Wealth & Trust's AGIO Position: Q1 2019 in Review

MassMutual Private Wealth & Trust sold out of Agios Pharmaceuticals (AGIO) in Q1 2019, closing a stake of 5,493 shares — an estimated $253K sold.

MassMutual Private Wealth & Trust first reported a position in AGIO in Q1 2018 and held it in 4 quarters. The position peaked at $428K in Q3 2018. 201 funds tracked by Wall St. Rank hold AGIO as of Q1 2019.

MassMutual Private Wealth & Trust reported no remaining Agios Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 5,493 Agios Pharmaceuticals shares in Q1 2019, an estimated $253K.
MassMutual Private Wealth & Trust first reported a position in Agios Pharmaceuticals in Q1 2018 and held it in 4 quarters.
MassMutual Private Wealth & Trust's Agios Pharmaceuticals position peaked at $428K in Q3 2018.
201 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2019.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2019, filed 15 May 2019.